Displaying drugs 151 - 175 of 408 in total
| Name | Weight | Structure | Desription | Categories |
|---|---|---|---|---|
| Corticotropin | 4541.0658 C207H308N56O58S |  | A diagnostic agent used in the screening of patients presumed to have adrenocortical insufficiency. | Adrenocorticotropic Hormone / Hormones / Melanocortins |
| Tirzepatide | 4810.52 C225H348N48O68 | | A dual GIP and GLP-1 receptor agonist used for the treatment of type II diabetes in adults as an adjunct to diet and exercise. | Blood Glucose Lowering Agents / Incretins |
| Lixisenatide | 4858.0 | | A GLP-1 receptor agonist used for the management of type 2 diabetes mellitus. | Glucagon-like peptide-1 (GLP-1) analogues |
| Insulin pork | 5795.6 C257H387N65O76S6 |  | A purified form of porcine insulin used to control hyperglycemia in diabetes mellitus. | Blood Glucose Lowering Agents / Insulins and Analogues for Injection, Fast-Acting |
| Insulin human | 5808.0 C257H383N65O77S6 |  | A recombinant form of human insulin used to control hyperglycemia in diabetes mellitus. | Blood Glucose Lowering Agents / Insulins and Analogues for Injection, Fast-Acting |
| Insulin lispro | 5808.0 C257H387N65O76S6 |  | A modified form of fast-acting insulin used to control hyperglycemia in diabetes mellitus. | Insulins and Analogues for Injection, Fast-Acting |
| Insulin glulisine | 5823.0 C258H384N64O78S6 | | A short-acting form of insulin used for glycemic control in type 1 and type 2 diabetes mellitus. | Insulins and Analogues for Injection, Fast-Acting |
| Insulin aspart | 5825.8 C256H381N65O79S6 |  | A rapid-acting form of insulin used for glycemic control in type 1 and type 2 diabetes mellitus. | Insulins and Analogues for Injection, Fast-Acting |
| Insulin detemir | 5916.9 C267H402N64O76S6 |  | A long-acting form of insulin used for glycemic control in type 1 and type 2 diabetes mellitus. | Blood Glucose Lowering Agents / Insulin Analog / Insulin, Long-Acting |
| Insulin glargine | 6063.0 C267H404N72O78S6 |  | A modified form of long-acting or basal insulin used to control hyperglycemia in diabetes mellitus. | Blood Glucose Lowering Agents / Hypolipidemic Agents / Insulin Analog / Insulin, Long-Acting |
| Insulin degludec | 6103.97 C274H411N65O81S6 |  | A long acting insulin used to treat hyperglycemia caused by type 1 and 2 diabetes mellitus. | Insulin Analog |
| Sulodexide | 6500.0 | | A drug used to treat chronic venous ulcers in the legs. | Anticoagulants / Heparin Group |
| Aprotinin | 6511.439 C284H432N84O79S7 |  | A serine protease inhibitor used to reduce the risk for perioperative blood loss and the need for blood transfusion in high-risk patients during cardiopulmonary bypass for coronary artery bypass graft surgery. | Proteinase Inhibitors |
| Lepirudin | 6979.0 C287H440N80O111S6 |  | A protein-based direct thrombin inhibitor used as an anticoagulant in patients with heparin-induced thrombocytopenia. | Anticoagulants / Antithrombins |
| Glatiramer | 7000.0 (C5H9NO4•C3H7NO2•C6H14N2O2•C9H11NO3)x•xC2H4O2 | | An immunomodulator used to reduce the frequency of relapses in Multiple Sclerosis (MS). | Adjuvants, Immunologic |
| Ecallantide | 7054.0 C305H442N88O91S8 | | A kallikrein inhibitor used to prevent and treat acute attacks caused by Hereditary Angioedema (HAE). | Drugs Used in Hereditary Angioedema |
| Mecasermin | 7649.0 C331H518N94O101S7 |  | A recombinant insulin-like growth factor-1 used for the long-term treatment of growth failure in pediatric patients with primary IGF-1 deficiency or with growth hormone gene deletion due to the development of neutralizing antibodies to GH. | Somatropin and Somatropin Agonists |
| Parathyroid hormone | 9420.0 C408H674N126O126S2 |  | An analog of human parathyroid hormone (PTH) used to treat hypocalcemia caused by hypoparathyroidism. | Parathyroid Hormones and Analogues |
| Becaplermin | 12294.4 C532H892N162O153S9 |  | A recombinant form of human platelet-derived growth factor used to treat ulcers due to diabetic neuropathy in the lower extremities when there is adequate blood supply to the area. | Angiogenesis Inducing Agents / DNA-Binding Proteins / Human Platelet-derived Growth Factor / Platelet-Derived Growth Factor / Proto-Oncogene Proteins / Proto-Oncogene Proteins c-sis |
| Nogapendekin alfa | 12770.45 | | An IL-15 receptor agonist used to treat BCG-unresponsive nonmuscle invasive bladder cancer (NMIBC) with carcinoma in situ (CIS) with or without papillary tumours. | Receptors, Interleukin-15 |
| Cenegermin | 13226.0 C583H908N166O173S8 | | A recombinant human nerve growth factor used to treat neurotrophic keratitis. | Recombinant Human Nerve Growth Factor |
| Sargramostim | 14434.5 C639H1006N168O196S8 |  | A modified form of recombinant human granulocyte-macrophage colony stimulating factor used to increase immune cell production after myelosuppressive therapy or bone marrow transplant. | Colony-Stimulating Factors |
| Aldesleukin | 15314.8 C690H1115N177O202S6 |  | A recombinant analog of interleukin-2 used to induce an adaptive immune response in the treatment of renal cell carcinoma. | Interleukins |
| Metreleptin | 16155.4429 C714H1167N191O221S6 |  | A leptin analogue used as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients various forms of lipodystrophy. | Amino Acids and Derivatives |
| Palifermin | 16192.7 C721H1142N202O204S9 |  | A form of recombinant human keratinocyte growth factor used to prevent and treat oral mucositis following radiation or chemotherapy. | Detoxifying Agents for Antineoplastic Treatment |
Displaying drugs 151 - 175 of 408 in total